Women's Cancer Research Foundation
Genital Powder Use and Epithelial Ovarian Cancer
Beginning in 2014, several lawsuits were filed against companies with talc products (baby powder) on behalf of women with ovarian cancer.
top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Search
Women's Cancer Research Foundation
- Oct 27, 2021
- 2 min
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
The lifetime risk of developing ovarian cancer in women who are not genetically susceptible to the disease is approximately 2%.
Women's Cancer Research Foundation
- Oct 22, 2021
- 1 min
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Analyses showed a longer duration of contraceptive use and more recent use were associated with a greater reduction in ovarian cancer risk.
Women's Cancer Research Foundation
- Oct 16, 2021
- 2 min
Women’s Health: 50 Years of Progress
Over the past 50 years, there have been tremendous advances in women’s health, particularly in treating cardiovascular disease and cancer.
Women's Cancer Research Foundation
- Oct 14, 2021
- 1 min
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
For the past ten yrs, continued use of bevacizumab therapy in the first-line treatment of ovarian cancer has reportedly improved...
Women's Cancer Research Foundation
- Oct 12, 2021
- 1 min
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Germline mutations in breast cancer predispose women to develop this malignancy, but in woman 65+years, the risk is not well-defined.
Women's Cancer Research Foundation
- Oct 8, 2021
- 1 min
Combination Strategies Reshape Treatment Paradigm for Advanced Endometrial Cancer
Initially, pembrolizumab was approved as a monotherapy for patients with microsatellite instability-high recurrent endometrial cancer.
Women's Cancer Research Foundation
- Oct 5, 2021
- 1 min
Blood Test for Many Cancer Types as Supplement to Screening
The blood test uses next-generation sequencing to analyze the arrangement of circulating cell-free DNA from a blood sample.
Women's Cancer Research Foundation
- Sep 20, 2021
- 1 min
Use of Hair Products in Relation to Ovarian Cancer Risk
In 2021 study conducted, the authors evaluated the potential impact of carcinogens from hair products that may be absorbed into bloodstream.
Women's Cancer Research Foundation
- Sep 15, 2021
- 2 min
Cognitive Function After Cancer and Cancer Treatment
Despite these advancements, the delayed effects from chemotherapy have become progressively concerning to patients.
Women's Cancer Research Foundation
- Sep 3, 2021
- 1 min
Association Between Breastfeeding and Ovarian Cancer Risk
The results from several oncology studies have indicated that breastfeeding is associated with a reduced risk of epithelial ovarian cancer.
Women's Cancer Research Foundation
- Aug 31, 2021
- 2 min
Women With Ovarian Cancer at Higher Risk for Mental Health Disorders
Ovarian cancer survivors who had a mental health diagnosis demonstrated an 80% higher risk for mortality.
Women's Cancer Research Foundation
- Aug 12, 2021
- 1 min
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Oral contraceptive use potentially reduces the risk of breast, ovarian, and endometrial cancers.
Women's Cancer Research Foundation
- Aug 5, 2021
- 1 min
Drug Boosts Survival for Women with Advanced Ovarian Cancer
Lynparza (Olaparib), a targeted cancer therapy, has recently shown a meaningful survival benefit after 5 years.
Women's Cancer Research Foundation
- Jul 27, 2021
- 2 min
Short-term Impact of Surgically Induced Menopause on Cognitive Function and Wellbeing
The short-term effect of surgically induced menopause on cognitive function and quality of life in women at high risk for ovarian cancer.
Women's Cancer Research Foundation
- Jul 5, 2021
- 1 min
Appropriateness of Specific Chemotherapy Regimens in Elderly Patients Diagnosed with Ovarian Cancer
Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian....
Women's Cancer Research Foundation
- Jun 30, 2021
- 1 min
Sleep quality and related factors in patients with breast cancer: A cross- sectional study in Taiwan
Researchers studied various factors related to post-treatment sleep disturbances in breast cancer patients.
Women's Cancer Research Foundation
- Jun 23, 2021
- 1 min
Associations Between Multimorbidity and Depression in Breast Cancer Survivors
Researchers used the UK Biobank (a national biomedical database) to examine the link between multimorbidity and depression.
Women's Cancer Research Foundation
- Jun 10, 2021
- 1 min
New blood test could reveal undiagnosed ovarian cancer in thousands of women
Researchers have developed a screening test for ovarian cancer that potentially detects the disease at earlier stages.
Women's Cancer Research Foundation
- Jun 3, 2021
- 2 min
HPV-Related Cancers Are on the Rise
With the Exception of Cervical Cancer, HPV-Related Cancers Are on the Rise, Especially in Older Adults
bottom of page